Clinical trial
Trial of Oxaloacetate in Amyotrophic Lateral Sclerosis
NCT04204889 is registered in ClinicalTrials.gov with Omar Jawdat as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial of Oxaloacetate in Amyotrophic Lateral Sclerosis
- Lead sponsor
- Omar Jawdat
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 17, 2020
- Completion date
- August 2, 2023
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
als